Finance

Beta
Lists
PRVA:NASDAQ
Privia Health Group Inc
$26.88
+4.47%
(+1.15) 1D
$26.88
0.00% (0.00)
After hours
Closed: Jul 1, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PRVA...
Open
$26.02
High
$27.11
Low
$25.84
Mkt. cap
3.39B
Avg. vol.
1.07M
Volume
1.00
P/E ratio
160.19
52-wk high
$27.11
52-wk low
$18.78
EPS
$0.17
Beta
0.90
Shares outstanding
126.01M
No. of employees
1K
Open
$26.02
High
$27.11
Low
$25.84
Mkt. cap
3.39B
Avg. vol.
1.07M
Volume
1.00
P/E ratio
160.19
52-wk high
$27.11
52-wk low
$18.78
EPS
$0.17
Beta
0.90
Shares outstanding
126.01M
No. of employees
1K
News stories
From sources across the web
About Privia Health Group Inc
CEO-
Employees1.23K
Founded2007
Headquarters-
SectorHealth care provider
Websitepriviahealth.com
Analyst ratings
Based on 11 analysts giving stock ratings to PRVA in the past 3 months
Strong buy
Buy
10
Hold
1
Sell
0
12-month forecast
Based on 11 Wall Street analysts offering 12 month price targets for PRVA in the last 3 months.
Highest
Current $26.88
$36.00 (+33.93%)
Average
$30.60 (+13.84%)
Lowest
$24.00 (-10.71%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jailendra Singh
Truist Financial
Buy
Maintained
$33.00
+22.8%
06/08/2026
Richard Close
Canaccord Genuity
Buy
Maintained
$34.00
+26.5%
05/28/2026
Andrew Mok CFA
Barclays
Hold
Maintained
$24.00
-10.7%
05/26/2026
Daniel Grosslight
Citi
Buy
Maintained
$32.00
+19%
05/13/2026
Ryan Langston
TD Cowen
Buy
Maintained
$30.00
+11.6%
05/11/2026
Ryan Halsted
RBC Capital
Buy
Reiterated
$31.00
+15.3%
05/07/2026
Sean Dodge
BMO Capital
Buy
Reiterated
$30.00
+11.6%
05/08/2026
Jessica Tassan
Piper Sandler
Buy
Reiterated
$36.00
+33.9%
05/08/2026
Matthew Shea
Needham
Buy
Reiterated
$30.00
+11.6%
05/07/2026
Elizabeth Anderson CFA
Evercore ISI
Buy
Maintained
$26.00
-3.3%
05/07/2026
Ryan Daniels
William Blair
Buy
Reiterated
-
-
05/07/2026
Lisa Gill
J.P. Morgan
Buy
Maintained
$35.00
+30.2%
03/06/2026
Unknown Analyst
BTIG
Buy
Maintained
$35.00
+30.2%
03/05/2026
Matthew Gillmor CFA
KeyBanc
Buy
Maintained
-
-
02/27/2026
Jack Slevin
Jefferies
Buy
Reiterated
$32.00
+19%
02/26/2026
Last report
May 7, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
$0.19 / $0.25
-24.09%miss
Revenue / Est. (USD)
603.85M / 561.93M
+7.46%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
521.15M
580.42M
541.17M
603.85M
Cost of goods sold
470.91M
516.65M
491.52M
543.54M
Cost of revenue
470.91M
516.65M
491.52M
543.54M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
44.32M
46.60M
35.72M
49.61M
Operating expense
46.91M
49.37M
38.38M
52.89M
Total operating expenses
517.82M
566.02M
529.90M
596.42M
Operating income
3.34M
14.40M
11.28M
7.42M
Other non operating income
-
-
-
-
EBT including unusual items
5.74M
16.67M
13.37M
9.31M
EBT excluding unusual items
5.74M
16.67M
13.37M
9.31M
Income tax expense
2.46M
6.87M
2.79M
5.60M
Effective tax rate
42.76%
41.18%
20.84%
60.15%
Other operating expenses
-
-
-
-
Net income
2.69M
6.86M
9.15M
3.06M
Net profit margin
0.52%
1.18%
1.69%
0.51%
Earnings per share
0.24
0.29
0.25
0.19
Interest and investment income
2.41M
2.27M
2.09M
1.89M
Interest expense
-
-
-
-
Net interest expenses
2.41M
2.27M
2.09M
1.89M
Depreciation and amortization charges
2.58M
2.77M
2.66M
3.28M
EBITDA
5.92M
17.17M
13.94M
10.70M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer